NICCI is Getinge’s latest innovation in Advanced Hemodynamic Monitoring, providing continuous and noninvasive hemodynamic insights to reduce the risk of severe complications for patients with low blood pressure GOTHENBURG, Sweden, Oct. 26, 2020 /PRNewswire/ — Blood pressure is one of the most important variables evaluated during almost every surgical intervention, but recent […]
Rhythm
GMAX Biopharm gives first does of anti-body drug treating PAH in phase 1B trial
HANGZHOU, China, Oct. 26, 2020 /PRNewswire/ — Gmax Biopharm today announces that the first dose of GMA301 was given to the patient in its phase 1B trial to investigate the drug efficacy to treat pulmonary arterial hypertension (PAH). GMA 301 is the first antibody drug for PAH treatment. In the phase 1A trial, it […]
UNC Researchers Identify Genetic Variant Linked to Drug-Induced Hypertension with Avastin®
Results from largest genomic analysis offer pathway to preventive patient screening CHAPEL HILL, N.C., Oct. 22, 2020 /PRNewswire/ — In the largest study of its kind, researchers from the University of North Carolina at Chapel Hill (UNC) have discovered a genetic variant that can be used to predict if patients will develop hypertension from […]
Dicerna Presents Positive New Interim Data From PHYOX™3 Long-Term, Open-Label Extension Study of Nedosiran for Treatment of Primary Hyperoxaluria (PH)
– All Participants Receiving Nedosiran, Regardless of Subtype, Achieved Normalization or Near-Normalization of Urinary Oxalate, a Key PH Measure, by Day 180 in Ongoing, Open-Label Trial – – Nedosiran Was Generally Well Tolerated With No Serious Safety Concerns Identified in This Ongoing Study – LEXINGTON, Mass.–(BUSINESS WIRE)–Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) […]
FineHeart Achieves Milestone for Its Miniaturized Heart Pump Technology With Successful Completion of 30-day Preclinical Study
The ICOMS device is the first destination therapy that restores natural heart pumping capacity This successful milestone is a major step towards first in human clinical trials BORDEAUX, France–(BUSINESS WIRE)–FineHeart, SA, a preclinical-stage medical device company developing an Implantable Cardiac Output Management System (ICOMS) to address the unmet need of […]
Cardiac Insight Increases Access to Lifesaving Wearable ECG AFib Detection Technology with Record Sales
Accelerating speed to diagnosis, allowing immediate access to patient ECG data, and enabling new revenue streams for physicians credited in rapid sales growth for leading ECG analysis platform BELLEVUE, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a healthcare innovator specializing in wearable cardiac sensors and automated electrocardiogram (ECG) analysis software that delivers highly […]
CinCor Pharma Announces First Patient Dosed with CIN-107 in Phase 2 Study in Treatment Resistant Hypertensive Subjects
CINCINNATI, Oct. 20, 2020 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (“CinCor”), a clinical-stage biopharmaceutical company developing medications targeting cardiovascular disease, announced today that they have dosed the first subject in the brigHTN study. The brigHTN study is a Phase 2 clinical trial evaluating the blood pressure lowering effects of CIN-107, […]
3M™ Littmann® Stethoscopes and Eko Announce New Collaboration
Bringing together science, technology, and comprehensive solutions to redefine what’s possible in healthcare ST. PAUL‚ Minn. & OAKLAND, Calif.–(BUSINESS WIRE)–As the world of healthcare and its dependence on auscultation continues to evolve, digital technology is being introduced to meet the advancing demands of the industry. To meet these changing needs, 3M™ […]
Swine Model Study of Hemorrhagic Shock Demonstrates Efficacy Of Biobeat’s Wearable Monitoring Device In Comparison To Invasive Arterial Line And Swan-Ganz Catheter Monitoring Methods
New Peer-Reviewed Study Substantiates Use Of Photoplethysmography-Based (PPG) Device To Help Accurately Monitor Patient Vitals, Even During Significant Hemodynamic Changes PETAH TIKVA, Israel, Oct. 19, 2020 /PRNewswire/ — Biobeat, a global leader in wearable remote patient monitoring solutions for the healthcare continuum, announced today the results of a swine model study comparing the hemodynamic […]
Altrix Medical, LLC Awarded Phase II Funding from the National Science Foundation
Small Business Innovation Research Program Provides Seed Funding for R&D CENTREVILLE, Va., Oct. 15, 2020 /PRNewswire/ — Altrix Medical, LLC has been awarded nearly $1 million from the National Science Foundation (NSF) to continue research and development (R&D) on a miniaturized automated external defibrillator (AED). This Small Business Innovation Research (SBIR) Phase 2 cooperative agreement funds the continued development of an integrated […]



